All filters
Slidesets
Practical Guidance Diabetes management - Introductory Talk -- Beatriz Gonzalez, MD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
How to Implement a Healthy Lifestyle in NAFLD/NASH Patients -- Shira Zelber-Sagi, PhD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
Drug-Induced Liver Injury and NASH -- Raúl Andrade, MD, PhD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
Cardiovascular Risk in NAFLD -- Jörn Schattenberg, MD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
Invited Lecturer -- Vlad Ratziu, MD, PhD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
Patient Perspective -- Maite Pujol
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
New Biomarkers in NAFLD -- Manuel Romero-Gomez, MD
Presented at:
European Workshop on NASH in Clinical Practice 2019
Slidesets
Integrating science, logistics and cost in approval of hierarchical testing strategies for NASH - The payer's perspective- Robert LoNigro, MD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Pathways and priorities for biomarker assessment- Peter Stein, MD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Repeatability, reproducibility and analytic standards for biomarker development- Abbas Bandukwala
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Linking “intended use” to evidence needed for bringing a biomarker to market- John Sninsky, PhD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Reporting standards: STARD & TRIPOD- Patrick Bossuyt, PhD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Quality standards for imaging studies- Claude Sirlin, MD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Case definitions for use as reference standards- Mohammed Siddiqui, MD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Defining the reference standard for biomarker development - Histology versus clinical outcomes- Kathleen Donohue, MD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
A Context of Use Framework for Bioanalytical Validation of the CK18 Apoptosis Biomarker for NASH Drug Development- Sumit Kar
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Serum markers of collagen formation are associated with the severity of Liver fibrosis and Non-Alcoholic Steatohepatitis (NASH) histological features and to impaired renal function (IRF) in a NAFLD cohort- Samuel Daniels
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
What is needed to link device approval to clinical application approval?- David Litwack, PhD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Algorithm to identify non-alcoholic steatohepatitis (NASH) patients with a NAS≥4 and F≥2: algorithm derived in an American screening cohort and validation in a British non-alcoholic fatty liver disease (NAFLD) cohort- Celine Fournier
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Study design to validate biomarkers of therapeutic response for pre-cirrhotic NASH- Brent Tetri, MD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Study design to validate biomarkers of therapeutic response in cirrhosis due to NASH- Detlef Schuppan, MD, PhD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
Defining therapeutic response in precirrhotic and cirrhotic NASH- Manal Abdelmalek , MD
Presented at:
International Workshop on NASH Biomarkers 2018
Slidesets
The clinical need for integrated assessment of NASH diabetes and heart disease- Arun Sanyal, MD, MBBS
Presented at:
International Workshop on NASH Biomarkers 2018